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Abstract
Background: Few data are available on subjects presenting to acute wards for the first time with psychotic symptoms.
The aims of this paper are (i) to describe the epidemiological and clinical characteristics of patients at their first
psychiatric admission (FPA), including socio-demographic features, risk factors, life habits, modalities of onset, psychiatric
diagnoses and treatments before admission; (ii) to assess the aggressive behavior and the clinical management of FPA
patients in Italian acute hospital psychiatric wards, called SPDCs (Servizio Psichiatrico Diagnosi e Cura = psychiatric
service for diagnosis and management).
Method: Cross-sectional observational multi-center study involving 62 Italian SPDCs (PERSEO – Psychiatric EmeRgency
Study and EpidemiOlogy).
Results: 253 FPA aged <= 40 were identified among 2521 patients admitted to Italian SPDCs over the 5-month study
period. About half of FPA patients showed an aggressive behavior as defined by a Modified Overt Aggression Scale
(MOAS) score greater than 0 Vs 46% of non-FPA patients (p = 0.3651). The most common was verbal aggression, while
about 20% of FPA patients actually engaged in physical aggression against other people. 74% of FPA patients had no
diagnosis at admission, while 40% had received a previous psychopharmacological treatment, mainly benzodiazepines and
antidepressants. During SPDC stay, diagnosis was established in 96% of FPA patients and a pharmacological therapy was
prescribed to 95% of them, mainly benzodiazepines, antipsychotics and mood stabilizers.
Conclusion: Subjects presenting at their first psychiatric ward admission have often not undergone previous adequate
psychiatric assessment and diagnostic procedures. The first hospital admission allows diagnosis and
psychopharmacological treatment to be established. In our population, aggressive behaviors were rather frequent,
although most commonly verbal. Psychiatric symptoms, as evaluated by psychiatrists and patients, improved significantly
from admission to discharge both for FPA and non-FPA patients.
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International studies show a growing recognition that
subjects presenting with psychotic symptoms for the first
time need specialized management [1]. However, few
data are available about the clinical characteristics of
patients at their first psychiatric admission (FPA), their
management, and their subjective well-being.
In Italy, a 1978 law provides that psychiatric patients can
only be admitted to hospital psychiatric wards, no other
admission (i.e. to psychiatric hospitals, which were in fact
abolished) shall be allowed. Very few epidemiological
studies have been carried out on psychiatric in-patients
since then. Acute hospital psychiatric wards are specific
structures (called SPDCs in Italy, Servizio Psichiatrico
Diagnosi e Cura = psychiatric service for diagnosis and
management), located within general hospitals, for refer-
ral of acute patients with psychiatric-related illnesses.
Patients stay in SPDCs only during the acute phase. At dis-
charge, they usually receive therapeutic prescriptions and
are no longer followed by SPDC services but by district
health facilities, which are not part of general hospitals
[2]. SPDCs could be the perfect setting for the study of
mentally ill patients at their first presentation to hospital,
although, in such emergency situations, the implementa-
tion of clinical research and epidemiology programs is
rather difficult. In fact, poor information is available
about clinical characteristics and behaviors of first admit-
ted patients. Moreover, little is known about the treat-
ments administered in SPDCs.
Aggression in psychiatric wards is common and represents
a growing concern for mental health professionals, due to
the increasing number of incidents [3-5]. However, recent
data suggest the importance of distinguishing between
different types of aggression [6,7]. Foley and co-workers
showed that individuals with first episode psychosis are at
high risk of demonstrating aggression at the time of pres-
entation to hospital, but at relatively low risk of develop-
ing a behavior likely to cause injury to other people [8].
PERSEO – Psychiatric EmeRgency Study and EpidemiOl-
ogy – is a large observational multi-center study involving
62 Italian SPDCs, aimed at assessing the prevalence and
incidence of aggressive behavior in patients admitted to
SPDCs and at describing the clinical features and the man-
agement of such patients. Within the admitted psychiatric
patients, the PERSEO study aimed at giving a detailed
description of FPA patients too. PERSEO follows EPICA, a
pilot study on 728 psychiatric cases enrolled in 15 Italian
SPDCs, where the Italian version of two psychometric
scales, namely the Modified Overt Aggression Scale
(MOAS) and the NOSIE (Nurses' Observation Scale for
In-patient Evaluation), were validated [9].
This report analyzes FPA patients only, among the PER-
SEO population, with the objective of describing their
clinical and treatment characteristics and their manage-
ment inside the SPDC.
Methods
PERSEO is a cross-sectional observational multi-center
study aimed at assessing some clinical and epidemiologi-
cal features of patients referring to Italian SPDCs, and in
particular: their socio-demographic characteristics, the
distribution of diagnoses, the prevalence of aggressive
behavior, the clinical picture at presentation to SPDCs
and the overall management and pharmacological treat-
ment approach in the emergency setting. Following
approval by the Ethics Committees of the participant
institutions and obtaining of the patients' written
informed consent, a cohort of 2521 consecutive subjects
aged 18 years or more presenting to 62 SPDCs distributed
throughout Italy between September 2003 and April 2004
was enrolled into the study. Patients were admitted to the
study only once over the enrolment period, and subjects
at their FPA were identified. Diagnosis at admission and
discharge was assessed according with ICD-9 CM criteria
and then grouped by diagnosis group [10].
The patients' clinical status was evaluated at admission,
then for the first three days of hospital stay and at dis-
charge or at day 30, whichever came first. Psychometric
evaluations included the 24 items Brief Psychiatric Rating
Scale (BPRS) [11], the Brief Symptoms Inventory (BSI)
[12], and the MOAS.
The MOAS [13] has been recently validated in Italian by
Margari et al. [9]. The MOAS records the onset, rates the
severity of aggression episodes and can be filled out by
nursing staff or physicians, on the basis of direct observa-
tion and clinical history of the 24 hours before the index
visit according with previous use by other authors
[8,14,15]. This scale includes four domains: verbal aggres-
sion, aggression against property, autoaggression, and
aggression towards others. Each subject was rated on a
scale between zero (no aggression) and four (maximum
score) on each domain. The scores were weighted as
described by Kay et al. [13] to calculate the total MOAS
score. Only scales thoroughly filled out both at admission
and discharge were considered for analysis. The preva-
lence of aggressive patients was then calculated as the pro-
portion of patients receiving a total MOAS score greater
then zero at admission (i.e. having shown at least one
aggressive behavior within 24 hours before admission)
among all patients evaluated for that scale. This dichot-
omization separates patients with no aggression from
those ones who had any severity and type of aggression,
either verbal, physical against self, others or objects.Page 2 of 10
(page number not for citation purposes)
BMC Psychiatry 2007, 7:3 http://www.biomedcentral.com/1471-244X/7/3Psychopathology was evaluated from the psychiatrist's
and the patient's point of view, by means of the BPRS and
the BSI respectively. The BPRS version 4.0 is a widely rec-
ognized symptomatic scale for the psychopathological
evaluation of patients and was validated in Italian by
Morosini et al [16]. It records the severity of symptoms on
a qualitative scale with 7 levels, ranging from 'absent' to
'very serious'. The total score and the domains' scores,
namely anxiety-depression, thought disorders, isolation-
motor retardation, hostility-suspiciousness, hyperactivity,
mania, were calculated [16]. BSI [11] is a self-evaluation
scale for general psychiatric symptoms. It covers 53 items,
which evaluate 9 elements: somatization, obsessive-com-
pulsive symptoms, interpersonal sensitivity, depression,
anxiety, hostility, phobic anxiety, paranoid ideation, psy-
choticism. The internal scores for each dimension of the
scale were calculated on the scales which were fully com-
pleted.
Among the overall PERSEO population, we focused on
FPA patients no older than 40. The 40 years age limit was
decided in order to exclude FPA due to late onset disorders
and to cognitive impairment or dementia, and also with
the aim of obtaining data possibly useful for the identifi-
cation of psychopathological risk factors and the charac-
teristics of the clinical onset.
Socio-demographic and anamnestic data, life habits, rea-
son for hospital admission, referring person, clinical eval-
uations, concomitant diseases, previous and ongoing
psychiatric treatment, admission and discharge diagnoses
and treatments administered in SPDC were recorded on
case record forms [10]. Specific data were recorded for FPA
patients only, such as symptoms at onset, patient manage-
ment at onset, pharmacological and non-pharmacologi-
cal treatment at onset and risk factors for the psychiatric
disease. Project and data management other than statistics
were conducted by MediData Studi e Ricerche. Data were
analyzed using SAS for Windows, release 8.2. All quanti-
tative variables were described by means, standard devia-
tions and ranges. Absolute and relative frequency
distributions were given for qualitative variables. Com-
parisons were performed by Student's t test for mean val-
ues, chi-square test, or Fisher exact test. When multiple
comparisons were performed Bonferroni's correction was
applied.
Results
Among the 2521 patients of the overall PERSEO popula-
tion, FPA patients aged < 40 years were 253 (10%). Their
socio-demographic characteristics are summarized in
Table 1. FPA patients were not statistically different from
non-FPA patients as regards gender distribution, life hab-
its (smoke and alcohol) and the admission status (p(chi-
square test)>0.05), whereas occupational and marital sta-
tus and drug abuse showed statistically different distribu-
tions (p < 0.001). Age was not compared between FPA
and non-FPA patients because one of the inclusion criteria
for the FPA group was "aged <= 40". Age distribution of
FPA (Table 2) was not significantly different between
males and females (Fisher exact test p > 0.05). However,
the frequency peak was 30–34 years among women and
25–29 among men. 94 (37.2%) FPA patients were
referred from a psychiatrist, 60 (23.7%) from other health
professionals (physician or psychologist), 99 (39.1%)
had not contacted a physician before admission to SPDC.
In 215 of FPA patients, at least one psychiatric symptom
was present at the onset, the most frequent being depres-
sive symptoms (51.4%), followed by positive (38.3%),
negative or cognitive (12.6%) symptoms, and manic
excitement (9.3%). The onset of symptoms was slow in
13.8% of patients, gradual in 51.4%, and acute in 28.9%.
The majority of patients at their FPA had neither a known
psychiatric diagnosis, nor had received previous psychiat-
ric treatments. In particular, only 66 (24.1%) FPA patients
had an admission diagnosis, as presented in Table 3 (left
column). 102 (40.3%) FPA patients had received a psy-
chopharmacological treatment before admission (Table
4, left column). This was not the case for non-FPA patients
who were admitted with a known diagnosis in 73% of
cases while 69% were under treatment before admission.
As far as risk factors are concerned, 65 FPA patients (26%)
had relatives with psychiatric disease, most commonly the
mother (47.7%), followed by the father (41.5%), then
brothers (21.5%), and sisters (15%). More than half of
FPA patients (57%) had experienced at least one stressful
event before the onset of psychiatric symptoms. Of these
stressful events, 63% were emotional or family-related,
17% were financial problems, and 10% were health prob-
lems.
236 (93.3%) FPA patients were evaluable for the MOAS.
About half of the FPA patients (49.2%) showed an aggres-
sive behavior during the day before admission, more com-
monly a verbal one (37.7%). Aggression against
properties and against other people accounted for 22.5%
of patients each The aggressive behavior pattern was sim-
ilar (Table 5) in the non-FPA cases (from the overall PER-
SEO population; p > 0.05). The most frequent diagnosis
among FPA patients showing aggressive behaviors was
schizophrenia (32.4% of aggressive patients). Aggressive
behaviors were more common among FPA patients,
whose admission was not voluntary (69%; p = 0.003),
while no difference in aggressive behaviors was observed
between males and females or across the different age
groups in FPA patients.Page 3 of 10
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in 238 (94.10%) FPA patients (Table 3, second column)
and a pharmacological therapy was prescribed to 239
(94.5%) (Table 4, second column). Psychiatric symp-
toms, as evaluated by psychiatrists (by BPRS) and patients
themselves (by BSI), improved significantly from admis-
sion to discharge for all domains, both for FPA and non-
FPA patients, as shown in Table 6. At admission, no statis-
tically significant differences were observed for BPRS
domains between FPA and non-FPA patients (p > 0.05),
whereas at discharge thought disorders, hyperactivity and
mania were significantly lower for FPA by comparison
with non-FPA patients (p < 0.01); the remaining domains
showed no statistical difference (p > 0.05). On the other
hand, no significant differences were observed between
FPA and non-FPA patients at admission or discharge for
BSI dimensions scores (p > 0.05).
Treatment at discharge for FPA patients was mainly ben-
zodiazepines (69% of cases), followed by atypical and
typical antipsychotics (51% and 38% respectively). This
pattern was not significantly different from the non-FPA
cases enrolled in the study (from the overall PERSEO pop-
ulation), given that, at discharge, 69% and 53% of non-
FPA patients were respectively on benzodiazepines and
atypical antipsychotics (p > 0.05, with Bonferroni correc-
tion for 5 multiple comparisons). A higher, though not
significant, proportion of non-FPA with typical antipsy-
chotics (46%) was found. A much lower proportion of
mood stabilizers was observed in FPA cases (21% Vs 35%
of non-FPA cases; p < 0.001, with Bonferroni correction
for 5 multiple comparisons); whereas a higher, though
not significant, percentage of antidepressants (41%) was
found in FPA by comparison with non-FPA patients
(34%; p = 0.2, with Bonferroni correction for 5 multiple
comparisons).
When psychiatric diagnosis is taken into account, benzo-
diazepines are still the most widely prescribed drugs in
FPA patients (ranging from 60% for "substance abuse"
Table 1: Socio-demographic characteristics of FPA patients
Gender(1), N (%) FPA patients (N = 253) Non-FPA patients (N = 2219)
Male 140 (55.3) 1118 (50.4)
Female 113 (44.7) 1101 (49.6)
Age, mean (SD) 30 (6.0) 45.2 (14.0)
Occupational status(2), N (%)
Employed 104 (41.1) 439 (19.8)
Housewife 30 (11.9) 298 (13.4)
Student 14 (5.5) 33 (1.5)
Unemployed 90 (35.6) 568 (25.6)
Other(3) 10 (3.9) 838 (37.8)
UKN 5 (2.0) 43 (1.9)
Marital status(2), N (%)
Single 139 (55.0) 940 (42.4)
Married 58 (22.9) 506 (22.8)
Widow 1 (0.4) 102 (4.6)
Divorced 14 (5.5) 257 (11.6)
UKN 41 (16.2) 414 (18.7)
Life habits, N (%)
Smokers(1) 138 (54.6) 1283 (57.8)
Alcohol abusers(1) 37 (14.6) 425 (19.2)
Drug abusers(2) 18 (7.1) 68 (3.1)
Admission status(1), N (%)
Voluntary 206 (81.4) 1897 (85.5)
Involuntary 47 (18.6) 317 (14.3)
UKN 0 (0.0) 5 (0.2)
(1) P(chi-square test between FPA and non-FPA patients)>0.05
(2) P(chi-square test between FPA and non-FPA patients)<0.005
(3) "Other" occupational status includes retired or unable-to-work patientsPage 4 of 10
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conventional antipsychotics are frequently given to FPA
patients diagnosed with schizophrenia, paranoid status or
other non organic psychoses (66% atypical, 55% typical).
Atypical drugs are administered also in case of personality
disorders (44%; 42% typical) or affective psychoses/
depressive episode-status (45%; 25% typical). Antidepres-
sants, as expected, were frequently prescribed to affective
psychoses, neurotic disorders and patients diagnosed with
acute stress/adaptive reaction (not shown).
Discussion
To our knowledge, there are very few large epidemiologi-
cal studies describing the socio-demographic and clinical
characteristics as well as the aggressive behavior of first
admitted patients to Italian psychiatric emergency struc-
tures, the SPDCs. The epidemiology of first episode psy-
choses and first psychiatric admissions is poorly
understood because of the paucity of systematic studies.
Yet, it is considered crucial for understanding psychiatric
disorders and aggressive behaviors at presentation to hos-
pital, in order to establish proper management [8,17,18].
A major problem is that, in emergency situations, the
implementation of clinical research and epidemiology
programs is rather difficult. Thus, little data are available
about clinical characteristics and behaviors of first episode
psychosis and FPA patients, as well as about the conduct
in psychiatric wards, both in Italy and in Europe. A few
years ago, the paucity of epidemiological studies carried
out in psychiatric emergency structures prompted some
Authors to stress the need to focus on the quality of diag-
nosis and management in such structures, as it happens
for community structures [19]. For this study, from the
overall 2521 cases collected by the PERSEO (Psychiatric
EmeRgency Study and EpidemiOlogy) project – a large
Italian observational multi-center study involving 62
SPDCs, aimed at assessing the prevalence and incidence of
aggressive behavior in patients admitted to a SPDC and at
describing the clinical features and management of such
patients – we selected a sample of 253 patients aged ≤ 40
years at FPA, which represents the largest studied popula-
tion of first admitted patients in Italian psychiatric emer-
gency structures. A comparison between FPA and non-FPA
patients is given here. However it is noteworthy that the
comparison between groups is not the aim of the study,
which is not a case-control. In fact, non-FPA patients were
not selected according to any pairing criterion.
Table 3: Diagnoses at admission to hospital psychiatric wards and at discharge. The percentage is calculated on patients with an 
established diagnosis at admission and at discharge within each group of patients.
FPA patients Non-FPA patients
Diagnosis Admission N (%) Discharge N (%) Admission N (%) Discharge N (%)
Affective psychosis, depression, depressive status 16 (24.2) 40 (17.4) 299 (16.6) 361 (17.1)
Schizophrenia, paranoid status, other non-organic psychosis 12 (18.2) 75 (31.5) 686 (38.2) 768 (36.3)
Substance abuse, dependence 9 (13.6) 17 (7.1) 85 (4.7) 118 (5.6)
Personality disorders 7 (10.6) 45 (18.9) 261 (14.5) 280 (13.2)
Neurotic disorders 7 (10.6) 22 (9.2) 70 (3.9) 81 (3.8)
Affective psychosis, manic episodes, excitement status 4 (6.1) 9 (3.8) 172 (9.6) 204 (9.6)
Schizoaffective psychosis 3 (4.5) 6 (2.5) 135 (7.5) 158 (7.5)
Dementia and psycho-organic syndromes 3 (4.5) 5 (2.1) 40 (2.2) 73 (3.5)
Acute stress reactions, adaptation reactions 1 (1.5) 12 (5.0) 11 (0.6) 35 (1.7)
Others 4 (6.1) 7 (2.9) 38 (2.1) 37 (1.7)
Total N. of patients with diagnosis 66 238 1797 2115
Table 2: Age distribution of FPA patients only, stratified by gender. Percentages are referred to the total number of FPA patients 
within gender
Age classes, N (%) Female Male
18–19 3 (2.7%) 5 (3.6%)
20–24 20 (17.7%) 26 (18.6%)
25–29 21 (18.6%) 38 (27.1%)
30–34 38 (33.6%) 33 (23.6%)
35–39 26 (23.0%) 35 (25.0%)
40 5 (4.4%) 3 (2.1%)Page 5 of 10
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females by comparison with males has been reported by
several authors, at least for schizophrenia, and the role of
estrogens in modulating serotoninergic function has been
discussed by numerous authors [20-23]. In our popula-
tion, there was no significant difference in age distribu-
tion at FPA between males and females, though the
frequency peak actually occurred about 5 years later
among women [30–34 years) than among men (25–29
years). The percentage of smokers was quite high among
our patients (54.6%), not surprisingly, as it is well known
that psychiatric patients are more vulnerable to nicotine-
dependence and that people with mental illness are about
twice as likely to smoke as others [24,25].
The most frequent diagnoses were depression and schizo-
phrenia both at admission and at discharge, even though
in an inverted frequency order, i.e. more depression diag-
noses at admission, more schizophrenia at discharge. This
is consistent with the 8-year interim results of an Irish epi-
demiological long term prospective study, the Cavan-
Monaghan study on first-episode psychosis [19], which
outlined that three are the primary diagnostic nodes at the
first psychotic episode, i.e. schizophrenia spectrum psy-
choses, bipolar disorder, and major depressive disorder,
around which there are numerous additional and overlap-
ping diagnostic categories, that are distinct only in terms
of their operational definition.
Psychiatric patients and individuals with schizophrenia in
particular are reported to engage in frequent and some-
times severe acts of aggression [26-28]. However, the
importance of distinguishing between different types of
aggression has been pointed out [6], and recent data by
Foley and co-workers, on 157 patients with a first episode
of DSM-psychosis presenting to a secondary referral psy-
chiatric service over a 4-year period, have shown that sub-
jects with first episode psychosis are at high risk of
demonstrating an aggressive behavior at the time of pres-
entation, but at relatively low risk of engaging aggression
against other people [8]. Our observational study seems
to confirm that FPA patients have more commonly a ver-
bally aggressive behavior, rather than a physical one
against self, properties or other people. However, the
prevalence of aggression against other people observed in
our survey is higher (22.5%) than that reported by Foley
(14%) [8] and by other authors. A 5-year Italian study on
1534 acute psychiatric in-patients reports 21% rate of
aggressive episodes, with 7.5% prevalence of physical
attacks [14], while a 3-year study on 934 psychiatric acute
ward patients in Norway reports 10.5% aggressive
patients [15].
Table 4: Psychopharmacological treatment before admission to hospital psychiatric wards and at discharge. Percentages are 
calculated on patients on treatment, at symptoms onset (FPA only) and at discharge.
Drug At symptoms onset N (%) Discharge N (%)
FPA patients only FPA Non-FPA
Benzodiazepine 49 (48.0) 157 (69.2) 1447 (69.4)
Antidepressant 48 (47.1) 92 (40.5) 703 (33.7)
Conventional antipsychotic 27 (26.5) 87 (38.3) 959 (46.0)
Atypical antipsychotic 18 (17.6) 115 (50.7) 1107 (53.1)
Mood stabilizer 7 (6.9) 48 (21.1) 726 (34.8)
Anticholinergic 3 (2.9) 27 (11.9) 234 (11.2)
Other 4 (3.9) 12 (5.2) 88 (4.2)
Total N. of patients on 
treatment
102 239 2084
Table 5: Prevalence of aggressive behavior in FPA patients, as expressed by MOAS. Percentages are calculated on patients valuable for 
MOAS, i.e. with MOAS fully compiled both at admission and discharge.
FPA patients (N = 236) Non-FPA patients (N = 2089)
MOAS scores, N (%)
Verbal 89 (37.7%) 791 (37.9%)
Against Properties 53 (22.5%) 373 (17.9%)
Against Self 48 (20.3%) 318 (15.2%)
Against Other People 53 (22.5%) 424 (20.3%)
Total Score 116 (49.1%) 962 (46.1%)Page 6 of 10
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observed, in terms of aggressive behavior, between FPA
and non-FPA patients, or between males and females. Pre-
vious data about gender differences in aggressive patients
are controversial: the Norwegian study by Mellesdal et al.
[15] reported no significant sex difference by total rate of
aggression, but a trend for female patients to have higher
rates of assaults, while Foley et al. [8] observed that males
had significantly higher MOAS total scores by comparison
with females, which does not exactly means a different
prevalence of aggressive behavior. Concerning the possi-
ble correlation between aggression and diagnosis or first
versus repeated admission, the Italian study by Grassi et
al. [14] reported that most aggressive patients had a diag-
nosis of schizophrenia and/or delusional syndromes
(55%) and previous psychiatric admissions (92%). Also
in our study, the most frequent diagnosis among aggres-
sive patients was schizophrenia, even though at a lower
extent (32%), while no difference was registered in FPA
versus non-FPA patients. In our study patients, a higher
percentage of involuntarily admitted individuals showed
at last one aggressive behavior, and this seems to defi-
nitely confirm previous observations that compulsory
admission is associated with aggression [8,29,30].
The differences we have shown between the PERSEO
study and other studies are difficult to interpret, as such
studies differ in study design, inclusion criteria, or meth-
ods for evaluation. In fact, while Grassi et al [14] used the
SOAS and defined aggressive all patients with a moderate
or severe aggression, in the PERSEO study the MOAS was
used and its total score was transformed into binary form
in order to have patients with no aggression vs patients
with any degree of aggression. Moreover Foley et al [8]
used the MOAS, but a different classification criteria of
aggressive behavior was applied: an individual was con-
sidered non-aggressive even when it scored greater than
zero on the subscale for verbal aggression.
An interesting aspect to be underlined is that, despite the
lack of a clearly defined diagnosis in the majority of our
FPA patients before admission, almost half of them had
received some kind of psychopharmacological treatment.
This finding seems to mirror those of other reports from
US studies [31,32] stating that many patients receiving
psychopharmacological treatment have not completed a
previous adequate clinical assessment and that only about
half of them actually meet the diagnostic criteria for a
mental disorder. During SPDC stay psychiatric diagnoses
were defined and pharmacological therapy was estab-
lished for almost all patients. Comparing the treatments
prescribed at discharge with those received by the patients
before admission, a high increase in the prescription of
antipsychotics, mainly atypical, and mood stabilizers is
observed. This may be explained by the fact that an ade-
quate clinical and diagnostic assessment, as performed in
the hospital setting, led to a more specific therapeutic
approach. Moreover, the trends in drug use from 1993 to
2002, as reported in several American and Italian pharma-
coepidemiological studies [33-36], show that there is an
increasing use in atypical antipsychotics prescription,
especially among psychiatric in-patients. Unfortunately,
Table 6: Scores of main BPRS domains and BSI symptom scales at admission and discharge.
FPA Non-FPA
Admission score Mean (SD) Discharge score Mean (SD) Admission score Mean (SD) Discharge score Mean (SD)
BPRS domains (items)
Anxiety-Depression (2-3-5) 10.2 (4.4) 6.5 (2.8) 9.5 (4.1) 6.2 (2.8)
Thought disorders (10-11-15) 7.4 (5.0) 4.6 (2.6) 8.0 (4.8) 5.4 (3.1)
Isolation-Motor retardation (16-17-18) 7.2 (4.3) 5.1 (2.8) 7.6 (4.3) 5.6 (2.9)
Hostility-Suspiciousness (6-9-20) 9.2 (5.1) 4.8 (2.5) 8.6 (4.7) 5.3 (2.8)
Hyperactivity (19-21-24) 6.5 (3.6) 4.0 (1.7) 6.8 (3.7) 4.5 (2.1)
Mania (7-22-23) 6.1 (3.9) 4.0 (1.9) 6.8 (4.2) 4.5 (2.3)
BSI symptom scales (items)
Somatization (2+7+23+29+30+33+37)/7 1.0 (0.9) 0.6 (0.6) 1.1 (0.9) 0.7 (0.7)
Obsessive-Compulsive 
(5+15+26+27+32+36)/6
1.3 (1.0) 0.9 (0.7) 1.4 (0.9) 1.0 (0.8)
Interpersonal sensitivity (20+21+22+42)/4 1.3 (1.0) 0.8 (0.8) 1.4 (1.0) 0.9 (0.8)
Depression (9+16+17+18+35+50)/6 1.5 (1.2) 0.9 (0.9) 1.6 (1.1) 1.1 (0.9)
Anxiety (1+12+19+38+45+49)/6 1.6 (1.0) 0.9 (0.8) 1.5 (1.0) 0.9 (0.8)
Hostility (6+13+40+41+46)/5 1.1 (0.9) 0.6 (0.7) 1.1 (0.9) 0.6 (0.7)
Phobic anxiety (8+28+31+43+47)/5 0.8 (0.8) 0.6 (0.7) 1.0 (0.9) 0.7 (0.7)
Paranoid ideation (4+10+24+48+51)/5 1.4 (1.0) 0.9 (0.8) 1.4 (1.0) 1.0 (0.8)
Psychoticism (3+14+34+44+53)/5 1.2 (0.9) 0.8 (0.8) 1.2 (0.9) 0.9 (0.8)
Total BSI 67.2 (40.8) 41.7 (32.7) 69.8 (39.5) 45.3 (33.6)Page 7 of 10
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because our study design and duration of follow-up were
insufficient for such an analysis.
Conclusion
In conclusion, our findings suggest that individuals pre-
senting at their first psychiatric ward admission have often
not undergone previous adequate psychiatric assessment
and diagnostic procedures. In our population, aggressive
behaviors were rather frequent, although more com-
monly verbal. The first hospital admission allowed diag-
nosis and psychopharmacological treatment to be
established in almost the totality of patients.
The strength of this study lies in the relatively large
number of FPA patients, although their description is lim-
ited to an Italian sample of psychiatric patients. This par-
ticular setting might be the reason of some differences we
have found in treatment and patient management. There-
fore, future surveys on psychiatric ward patients should
address two further objectives: first, the identification of
possible patient-staff interactions and of situations favor-
ing or precipitating the aggressions; secondly, the assess-
ment of the adequacy of the established therapy.
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